期刊
CELL HOST & MICROBE
卷 29, 期 6, 页码 904-+出版社
CELL PRESS
DOI: 10.1016/j.chom.2021.04.014
关键词
-
资金
- CIHR [422148]
- NIH [R33AI122384, R01AI145164, R01 AI150322, AI148379]
- CHEETAH grant [P50AI150464, R56AI141572]
- American Foundation for AIDS Research (AmfAR) [109343-59-RGRL, R01 AI129769]
- Gilead via its HIV Cure Program
- Howard Hughes Medical Institute
- CIHR doctoral fellowships
- AmfAR Mathilde Krim Fellowship [109720-63-RKRL]
- Canada Research Chair on Retroviral Entry
- [R01 AI116274]
- [R01 AI050529]
- [UM1 AI126620]
- [P01-GM56550/AI150741]
Research has shown that CD4mc can sensitize HIV-1-infected cells to ADCC by facilitating antibody recognition of epitopes on the viral envelope that are otherwise occluded. Combining CD4mc with specific antibodies can reduce viral replication and reservoir size by enhancing ADCC. The dependence on NK cells and Fc effector functions for these effects highlights the importance of ADCC in combating HIV-1.
Small CD4-mimetic compounds (CD4mc) sensitize HIV-1 -infected cells to antibody-dependent cellular cytotoxicity (ADCC) by facilitating antibody recognition of epitopes that are otherwise occluded on the unliganded viral envelope (Env). Combining CD4mc with two families of CD4-induced (CD4i) antibodies, which are frequently found in plasma of HIV-1-infected individuals, stabilizes Env in a conformation that is vulnerable to ADCC. We employed new-generation SRG-15 humanized mice, supporting natural killer (NK) cell and Fc-effector functions to demonstrate that brief treatment with CD4mc and CD4i-Abs significantly decreases HIV-1 replication, the virus reservoir and viral rebound after ART interruption. These effects required Fc-effector functions and NK cells, highlighting the importance of ADCC. Viral rebound was also suppressed in HIV-1+-donor cell-derived humanized mice supplemented with autologous HIV-1+-donor-derived plasma and CD4mc. These results indicate that CD4mc could have therapeutic utility in infected individuals for decreasing the size of the HIV-1 reservoir and/or achieving a functional cure.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据